Candel Therapeutics, Inc. CADL Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $194.83M+111% | $119.73M+16.6% | $86.96M+425% | $100.69M+369% | $92.17M+258% | ||
| $416K+56.4% | $416K+56.4% | $266K0.0% | $266K0.0% | $266K0.0% | ||
| $2.92M+197% | $1.66M+44.2% | $3.17M+108% | $2.92M+128% | $983K-30.9% | ||
| $197.75M+112% | $121.39M+16.9% | $90.13M+398% | $103.61M+356% | $93.15M+243% | ||
| $2.08M+5.6% | $1.64M-25.1% | $1.36M-45.0% | $1.66M-39.0% | $1.97M-33.7% | ||
| $1.57M+235% | $1.66M+206% | $1.75M+185% | $391K-42.8% | $468K-37.7% | ||
| $108K+86.2% | $87K+38.1% | $85K+13.3% | $45K-44.4% | $58K-43.1% | ||
| $201.92M+111% | $125.2M+17.2% | $93.6M+335% | $105.97M+300% | $95.91M+207% | ||
| $3.04M+299% | $1.13M+376% | $1.12M+278% | $1.95M+351% | $760K+61.0% | ||
| $89K-96.7% | $89K— | $5.15M+12.7% | $4.32M+34.3% | $2.72M-1.9% | ||
| $67K— | $89K— | —— | —— | —— | ||
| —— | $0-100% | $4.23M-57.1% | $6.7M-31.7% | $9.17M-6.1% | ||
| $453K-21.9% | $445K-21.4% | $437K-20.8% | $594K+10.2% | $580K+10.3% | ||
| $7.05M-64.9% | $9M-76.0% | $10.93M-28.4% | $14.72M+5.1% | $20.07M+48.3% | ||
| $1.05M+15.8% | $1.01M+15.9% | $973K+15.8% | $939K+15.9% | $904K+15.7% | ||
| $1.34M+423% | $1.46M+258% | $1.57M+183% | $104K-85.1% | $257K-69.3% | ||
| $1.8M+115% | $1.9M+95.7% | $2.01M+81.5% | $698K-43.6% | $837K-38.6% | ||
| $63.89M+201% | $73.27M+80.7% | $13.47M-63.4% | $15.76M-56.8% | $21.23M-15.9% | ||
| $733K+48.7% | $550K+17.3% | $550K+70.8% | $549K+81.2% | $493K+68.8% | ||
| $376.99M+45.3% | $282.21M+9.2% | $280.91M+72.3% | $279.73M+77.4% | $259.46M+71.4% | ||
| -$239.25M-29.4% | -$230.39M-19.9% | -$200.89M-12.8% | -$189.62M-13.2% | -$184.83M-27.2% | ||
| $448K0.0% | $448K0.0% | $448K0.0% | $448K0.0% | $448K0.0% | ||
| $138.03M+84.8% | $51.92M-21.7% | $80.12M+625% | $90.21M+1,005% | $74.68M+1,149% | ||
| $201.92M+111% | $125.2M+17.2% | $93.6M+335% | $105.97M+300% | $95.91M+207% | ||
| $1.57M+235% | $1.66M+206% | $1.75M+185% | $391K-42.8% | $468K-37.7% | ||
| $1.57M+235% | $1.66M+206% | $1.75M+185% | $391K-42.8% | $468K-37.7% | ||
| $108K+86.2% | $87K+38.1% | $85K+13.3% | $45K-44.4% | $58K-43.1% | ||
| $1.57M+235% | $1.66M+206% | $1.75M+185% | $391K-42.8% | $468K-37.7% | ||
| $3.47M+27.7% | $7.33M+43.4% | $5.15M+12.7% | $4.32M+34.3% | $2.72M-1.9% | ||
| $3.47M+27.7% | $7.33M+43.4% | $5.15M+12.7% | $4.32M+34.3% | $2.72M-1.9% | ||
| $89K— | $89K— | —— | —— | —— | ||
| $67K— | $89K— | —— | —— | —— | ||
| $2.84M-73.9% | $2.91M-75.2% | $7.21M-38.9% | $8.34M-29.6% | $10.91M-8.4% | ||
| $376.99M+45.3% | $282.21M+9.2% | $280.91M+72.3% | $279.73M+77.4% | $259.46M+71.4% | ||
| $733K+48.7% | $550K+17.3% | $550K+70.8% | $549K+81.2% | $493K+68.8% | ||
| $448K0.0% | $448K0.0% | $448K0.0% | $448K0.0% | $448K0.0% | ||
| $7.96M— | $15.6M— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Candel Therapeutics, Inc.'s total assets?
- Candel Therapeutics, Inc. (CADL) holds $201.9M in total assets, up 110.5% year over year.
- How much debt does Candel Therapeutics, Inc. have?
- Candel Therapeutics, Inc. carries $2.8M in total debt against $138.0M of shareholders' equity, a debt-to-equity ratio of 0.02.
- How much cash does Candel Therapeutics, Inc. have?
- Candel Therapeutics, Inc. holds $194.8M in cash and equivalents.
- Can Candel Therapeutics, Inc. cover its short-term obligations?
- Its current ratio is 28.05 — current assets exceed current liabilities.
- Where does Candel Therapeutics, Inc.'s balance sheet data come from?
- Every line is extracted from Candel Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
